nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00497	0.0362	CbGpPWpGaD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00454	0.0331	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00445	0.0324	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00427	0.0311	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00427	0.0311	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00401	0.0292	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00395	0.0288	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00379	0.0276	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00359	0.0262	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00345	0.0251	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors—NR3C1—glaucoma	0.00271	0.0197	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptors—NR3C1—glaucoma	0.00248	0.0181	CbGpPWpGaD
Isotretinoin—RXRA—Endogenous sterols—CYP1B1—glaucoma	0.00246	0.0179	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors—NR3C1—glaucoma	0.00243	0.0177	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—IL1A—glaucoma	0.00235	0.0171	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptors—NR3C1—glaucoma	0.00233	0.017	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—NR3C1—glaucoma	0.00233	0.017	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00223	0.0162	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—IL1A—glaucoma	0.00221	0.0161	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00214	0.0156	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00197	0.0144	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00196	0.0143	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00192	0.014	CbGpPWpGaD
Isotretinoin—RXRG—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.0019	0.0138	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—NR3C1—glaucoma	0.00188	0.0137	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00184	0.0134	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00184	0.0134	CbGpPWpGaD
Isotretinoin—RXRB—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.00179	0.013	CbGpPWpGaD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.00151	0.011	CbGpPWpGaD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.00138	0.0101	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.00136	0.00987	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.0013	0.00946	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.0013	0.00946	CbGpPWpGaD
Isotretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NR3C1—glaucoma	0.00124	0.00904	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptors—NR3C1—glaucoma	0.00122	0.00885	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—IL1A—glaucoma	0.00115	0.0084	CbGpPWpGaD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00114	0.0083	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.00111	0.00807	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SLC6A13—glaucoma	0.0011	0.00803	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.00106	0.00774	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00096	0.00699	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.000931	0.00678	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—NR3C1—glaucoma	0.000927	0.00675	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000924	0.00673	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—TXN—glaucoma	0.000906	0.0066	CbGpPWpGaD
Isotretinoin—RXRA—Circadian Clock—NR3C1—glaucoma	0.000904	0.00658	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—FAS—glaucoma	0.000898	0.00654	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—NR3C1—glaucoma	0.000872	0.00635	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—FAS—glaucoma	0.000845	0.00615	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000826	0.00602	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SLC6A1—glaucoma	0.000807	0.00588	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000792	0.00577	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—PEX19—glaucoma	0.000784	0.00571	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—glaucoma	0.000774	0.00564	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000762	0.00554	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000757	0.00551	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.00073	0.00532	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000725	0.00528	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—ABCA1—glaucoma	0.000702	0.00511	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000687	0.005	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000677	0.00493	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—TGFB2—glaucoma	0.000658	0.00479	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000648	0.00471	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000621	0.00452	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GSTT1—glaucoma	0.000616	0.00449	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000554	0.00403	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000554	0.00403	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000531	0.00387	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00053	0.00386	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP1B1—glaucoma	0.000491	0.00357	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000473	0.00345	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000459	0.00334	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—NR3C1—glaucoma	0.000454	0.00331	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—GSTM1—glaucoma	0.000447	0.00326	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—FAS—glaucoma	0.00044	0.0032	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CA5A—glaucoma	0.000432	0.00314	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NARFL—glaucoma	0.000432	0.00314	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—CDKN2B—glaucoma	0.000422	0.00307	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000413	0.00301	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000407	0.00296	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GSTM1—glaucoma	0.000392	0.00286	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.00039	0.00284	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NCK2—glaucoma	0.000389	0.00283	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—CDKN2B—glaucoma	0.000386	0.00281	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000386	0.00281	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—TNF—glaucoma	0.000381	0.00278	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000381	0.00277	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—CDKN2B—glaucoma	0.000378	0.00275	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000378	0.00275	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—NR3C1—glaucoma	0.00037	0.00269	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.00037	0.00269	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—CDKN2B—glaucoma	0.000363	0.00264	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—CDKN2B—glaucoma	0.000363	0.00264	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—TNF—glaucoma	0.000359	0.00261	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000353	0.00257	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—NR3C1—glaucoma	0.000339	0.00246	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—NR3C1—glaucoma	0.000332	0.00242	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000324	0.00236	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000321	0.00234	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—NR3C1—glaucoma	0.000318	0.00232	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—NR3C1—glaucoma	0.000318	0.00232	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000308	0.00224	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—glaucoma	0.000284	0.00207	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000277	0.00201	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000275	0.002	CbGpPWpGaD
Isotretinoin—Syncope—Clonidine—glaucoma	0.000275	0.000319	CcSEcCtD
Isotretinoin—Arrhythmia—Betaxolol—glaucoma	0.000274	0.000317	CcSEcCtD
Isotretinoin—Feeling abnormal—Dorzolamide—glaucoma	0.000273	0.000317	CcSEcCtD
Isotretinoin—Decreased appetite—Pilocarpine—glaucoma	0.000272	0.000316	CcSEcCtD
Isotretinoin—Feeling abnormal—Travoprost—glaucoma	0.000272	0.000315	CcSEcCtD
Isotretinoin—Conjunctivitis—Timolol—glaucoma	0.000271	0.000314	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Dorzolamide—glaucoma	0.000271	0.000314	CcSEcCtD
Isotretinoin—Alopecia—Betaxolol—glaucoma	0.000271	0.000314	CcSEcCtD
Isotretinoin—Palpitations—Clonidine—glaucoma	0.000271	0.000314	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00027	0.000314	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Travoprost—glaucoma	0.00027	0.000313	CcSEcCtD
Isotretinoin—Loss of consciousness—Clonidine—glaucoma	0.000269	0.000312	CcSEcCtD
Isotretinoin—Feeling abnormal—Brinzolamide—glaucoma	0.000269	0.000311	CcSEcCtD
Isotretinoin—Mental disorder—Betaxolol—glaucoma	0.000269	0.000311	CcSEcCtD
Isotretinoin—Pain—Pilocarpine—glaucoma	0.000268	0.000311	CcSEcCtD
Isotretinoin—Constipation—Pilocarpine—glaucoma	0.000268	0.000311	CcSEcCtD
Isotretinoin—Cough—Clonidine—glaucoma	0.000268	0.00031	CcSEcCtD
Isotretinoin—Sweating—Timolol—glaucoma	0.000267	0.00031	CcSEcCtD
Isotretinoin—Dizziness—Apraclonidine—glaucoma	0.000267	0.00031	CcSEcCtD
Isotretinoin—Erythema—Betaxolol—glaucoma	0.000267	0.000309	CcSEcCtD
Isotretinoin—Malnutrition—Betaxolol—glaucoma	0.000267	0.000309	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000264	0.00192	CbGpPWpGaD
Isotretinoin—Urticaria—Dorzolamide—glaucoma	0.000263	0.000305	CcSEcCtD
Isotretinoin—Epistaxis—Timolol—glaucoma	0.000263	0.000305	CcSEcCtD
Isotretinoin—Abdominal pain—Dorzolamide—glaucoma	0.000262	0.000304	CcSEcCtD
Isotretinoin—Body temperature increased—Dorzolamide—glaucoma	0.000262	0.000304	CcSEcCtD
Isotretinoin—Tension—Betaxolol—glaucoma	0.000262	0.000304	CcSEcCtD
Isotretinoin—Sinusitis—Timolol—glaucoma	0.000262	0.000303	CcSEcCtD
Isotretinoin—Arthralgia—Clonidine—glaucoma	0.000261	0.000303	CcSEcCtD
Isotretinoin—Chest pain—Clonidine—glaucoma	0.000261	0.000303	CcSEcCtD
Isotretinoin—Abdominal pain—Travoprost—glaucoma	0.000261	0.000303	CcSEcCtD
Isotretinoin—Agranulocytosis—Timolol—glaucoma	0.00026	0.000302	CcSEcCtD
Isotretinoin—Anxiety—Clonidine—glaucoma	0.00026	0.000301	CcSEcCtD
Isotretinoin—Asthenia—Acetazolamide—glaucoma	0.00026	0.000301	CcSEcCtD
Isotretinoin—Dizziness—Bimatoprost—glaucoma	0.000259	0.000301	CcSEcCtD
Isotretinoin—Nervousness—Betaxolol—glaucoma	0.000259	0.0003	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000259	0.0003	CcSEcCtD
Isotretinoin—Urticaria—Brinzolamide—glaucoma	0.000259	0.0003	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000259	0.00188	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Pilocarpine—glaucoma	0.000258	0.000299	CcSEcCtD
Isotretinoin—Discomfort—Clonidine—glaucoma	0.000258	0.000299	CcSEcCtD
Isotretinoin—Vomiting—Apraclonidine—glaucoma	0.000257	0.000298	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Pilocarpine—glaucoma	0.000256	0.000297	CcSEcCtD
Isotretinoin—Hypersensitivity—Brimonidine—glaucoma	0.000256	0.000297	CcSEcCtD
Isotretinoin—Dry mouth—Clonidine—glaucoma	0.000255	0.000296	CcSEcCtD
Isotretinoin—Dermatitis—Apraclonidine—glaucoma	0.000255	0.000295	CcSEcCtD
Isotretinoin—Headache—Apraclonidine—glaucoma	0.000253	0.000294	CcSEcCtD
Isotretinoin—Confusional state—Clonidine—glaucoma	0.000252	0.000292	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—PAX6—glaucoma	0.000252	0.00184	CbGpPWpGaD
Isotretinoin—Vision blurred—Betaxolol—glaucoma	0.000252	0.000292	CcSEcCtD
Isotretinoin—Oedema—Clonidine—glaucoma	0.00025	0.00029	CcSEcCtD
Isotretinoin—Tremor—Betaxolol—glaucoma	0.00025	0.00029	CcSEcCtD
Isotretinoin—Hallucination—Timolol—glaucoma	0.000249	0.000289	CcSEcCtD
Isotretinoin—Asthenia—Brimonidine—glaucoma	0.000249	0.000289	CcSEcCtD
Isotretinoin—Infection—Clonidine—glaucoma	0.000249	0.000288	CcSEcCtD
Isotretinoin—Body temperature increased—Pilocarpine—glaucoma	0.000248	0.000287	CcSEcCtD
Isotretinoin—Abdominal pain—Pilocarpine—glaucoma	0.000248	0.000287	CcSEcCtD
Isotretinoin—Ill-defined disorder—Betaxolol—glaucoma	0.000248	0.000287	CcSEcCtD
Isotretinoin—Diarrhoea—Acetazolamide—glaucoma	0.000247	0.000287	CcSEcCtD
Isotretinoin—Rash—Bimatoprost—glaucoma	0.000247	0.000287	CcSEcCtD
Isotretinoin—Dermatitis—Bimatoprost—glaucoma	0.000247	0.000286	CcSEcCtD
Isotretinoin—Oedema peripheral—Timolol—glaucoma	0.000247	0.000286	CcSEcCtD
Isotretinoin—Anaemia—Betaxolol—glaucoma	0.000247	0.000286	CcSEcCtD
Isotretinoin—Shock—Clonidine—glaucoma	0.000246	0.000285	CcSEcCtD
Isotretinoin—Pruritus—Brimonidine—glaucoma	0.000246	0.000285	CcSEcCtD
Isotretinoin—Headache—Bimatoprost—glaucoma	0.000246	0.000285	CcSEcCtD
Isotretinoin—Nervous system disorder—Clonidine—glaucoma	0.000245	0.000284	CcSEcCtD
Isotretinoin—Thrombocytopenia—Clonidine—glaucoma	0.000245	0.000284	CcSEcCtD
Isotretinoin—Hypersensitivity—Dorzolamide—glaucoma	0.000244	0.000283	CcSEcCtD
Isotretinoin—Tachycardia—Clonidine—glaucoma	0.000244	0.000283	CcSEcCtD
Isotretinoin—Hypersensitivity—Travoprost—glaucoma	0.000243	0.000282	CcSEcCtD
Isotretinoin—Skin disorder—Clonidine—glaucoma	0.000243	0.000282	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000242	0.00176	CbGpPWpGaD
Isotretinoin—Hyperhidrosis—Clonidine—glaucoma	0.000242	0.00028	CcSEcCtD
Isotretinoin—Visual impairment—Timolol—glaucoma	0.000241	0.00028	CcSEcCtD
Isotretinoin—Malaise—Betaxolol—glaucoma	0.000241	0.000279	CcSEcCtD
Isotretinoin—Nausea—Apraclonidine—glaucoma	0.00024	0.000278	CcSEcCtD
Isotretinoin—Hypersensitivity—Brinzolamide—glaucoma	0.00024	0.000278	CcSEcCtD
Isotretinoin—Syncope—Betaxolol—glaucoma	0.000239	0.000277	CcSEcCtD
Isotretinoin—Dizziness—Acetazolamide—glaucoma	0.000239	0.000277	CcSEcCtD
Isotretinoin—Anorexia—Clonidine—glaucoma	0.000238	0.000276	CcSEcCtD
Isotretinoin—Asthenia—Dorzolamide—glaucoma	0.000238	0.000276	CcSEcCtD
Isotretinoin—Asthenia—Travoprost—glaucoma	0.000237	0.000275	CcSEcCtD
Isotretinoin—Palpitations—Betaxolol—glaucoma	0.000236	0.000273	CcSEcCtD
Isotretinoin—Pruritus—Dorzolamide—glaucoma	0.000235	0.000272	CcSEcCtD
Isotretinoin—Loss of consciousness—Betaxolol—glaucoma	0.000235	0.000272	CcSEcCtD
Isotretinoin—Eye disorder—Timolol—glaucoma	0.000234	0.000271	CcSEcCtD
Isotretinoin—Asthenia—Brinzolamide—glaucoma	0.000234	0.000271	CcSEcCtD
Isotretinoin—Hypotension—Clonidine—glaucoma	0.000234	0.000271	CcSEcCtD
Isotretinoin—Pruritus—Travoprost—glaucoma	0.000234	0.000271	CcSEcCtD
Isotretinoin—Tinnitus—Timolol—glaucoma	0.000234	0.000271	CcSEcCtD
Isotretinoin—Cough—Betaxolol—glaucoma	0.000233	0.00027	CcSEcCtD
Isotretinoin—Nausea—Bimatoprost—glaucoma	0.000233	0.00027	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000232	0.00169	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Pilocarpine—glaucoma	0.000231	0.000268	CcSEcCtD
Isotretinoin—Pruritus—Brinzolamide—glaucoma	0.000231	0.000267	CcSEcCtD
Isotretinoin—Vomiting—Acetazolamide—glaucoma	0.00023	0.000267	CcSEcCtD
Isotretinoin—Dizziness—Brimonidine—glaucoma	0.00023	0.000266	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Clonidine—glaucoma	0.000228	0.000264	CcSEcCtD
Isotretinoin—Angiopathy—Timolol—glaucoma	0.000227	0.000263	CcSEcCtD
Isotretinoin—Myalgia—Betaxolol—glaucoma	0.000227	0.000263	CcSEcCtD
Isotretinoin—Arthralgia—Betaxolol—glaucoma	0.000227	0.000263	CcSEcCtD
Isotretinoin—Chest pain—Betaxolol—glaucoma	0.000227	0.000263	CcSEcCtD
Isotretinoin—Diarrhoea—Dorzolamide—glaucoma	0.000227	0.000263	CcSEcCtD
Isotretinoin—Headache—Acetazolamide—glaucoma	0.000227	0.000263	CcSEcCtD
Isotretinoin—Anxiety—Betaxolol—glaucoma	0.000226	0.000262	CcSEcCtD
Isotretinoin—Insomnia—Clonidine—glaucoma	0.000226	0.000262	CcSEcCtD
Isotretinoin—Diarrhoea—Travoprost—glaucoma	0.000226	0.000262	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000226	0.000262	CcSEcCtD
Isotretinoin—Asthenia—Pilocarpine—glaucoma	0.000225	0.000261	CcSEcCtD
Isotretinoin—Paraesthesia—Clonidine—glaucoma	0.000225	0.00026	CcSEcCtD
Isotretinoin—Discomfort—Betaxolol—glaucoma	0.000224	0.00026	CcSEcCtD
Isotretinoin—Arrhythmia—Timolol—glaucoma	0.000224	0.000259	CcSEcCtD
Isotretinoin—Dyspnoea—Clonidine—glaucoma	0.000223	0.000259	CcSEcCtD
Isotretinoin—Diarrhoea—Brinzolamide—glaucoma	0.000223	0.000259	CcSEcCtD
Isotretinoin—Somnolence—Clonidine—glaucoma	0.000222	0.000258	CcSEcCtD
Isotretinoin—Dry mouth—Betaxolol—glaucoma	0.000222	0.000258	CcSEcCtD
Isotretinoin—Pruritus—Pilocarpine—glaucoma	0.000222	0.000257	CcSEcCtD
Isotretinoin—Alopecia—Timolol—glaucoma	0.000221	0.000257	CcSEcCtD
Isotretinoin—Confusional state—Betaxolol—glaucoma	0.00022	0.000255	CcSEcCtD
Isotretinoin—Mental disorder—Timolol—glaucoma	0.000219	0.000254	CcSEcCtD
Isotretinoin—Dizziness—Dorzolamide—glaucoma	0.000219	0.000254	CcSEcCtD
Isotretinoin—Rash—Brimonidine—glaucoma	0.000219	0.000254	CcSEcCtD
Isotretinoin—Dermatitis—Brimonidine—glaucoma	0.000219	0.000254	CcSEcCtD
Isotretinoin—Dizziness—Travoprost—glaucoma	0.000218	0.000253	CcSEcCtD
Isotretinoin—Erythema—Timolol—glaucoma	0.000218	0.000253	CcSEcCtD
Isotretinoin—Malnutrition—Timolol—glaucoma	0.000218	0.000253	CcSEcCtD
Isotretinoin—Oedema—Betaxolol—glaucoma	0.000218	0.000252	CcSEcCtD
Isotretinoin—Headache—Brimonidine—glaucoma	0.000217	0.000252	CcSEcCtD
Isotretinoin—Decreased appetite—Clonidine—glaucoma	0.000217	0.000252	CcSEcCtD
Isotretinoin—Infection—Betaxolol—glaucoma	0.000216	0.000251	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Clonidine—glaucoma	0.000216	0.00025	CcSEcCtD
Isotretinoin—Fatigue—Clonidine—glaucoma	0.000216	0.00025	CcSEcCtD
Isotretinoin—Dizziness—Brinzolamide—glaucoma	0.000216	0.00025	CcSEcCtD
Isotretinoin—Nausea—Acetazolamide—glaucoma	0.000215	0.000249	CcSEcCtD
Isotretinoin—Diarrhoea—Pilocarpine—glaucoma	0.000214	0.000248	CcSEcCtD
Isotretinoin—Shock—Betaxolol—glaucoma	0.000214	0.000248	CcSEcCtD
Isotretinoin—Tension—Timolol—glaucoma	0.000214	0.000248	CcSEcCtD
Isotretinoin—Constipation—Clonidine—glaucoma	0.000214	0.000248	CcSEcCtD
Isotretinoin—Pain—Clonidine—glaucoma	0.000214	0.000248	CcSEcCtD
Isotretinoin—Nervous system disorder—Betaxolol—glaucoma	0.000214	0.000248	CcSEcCtD
Isotretinoin—Thrombocytopenia—Betaxolol—glaucoma	0.000213	0.000247	CcSEcCtD
Isotretinoin—Tachycardia—Betaxolol—glaucoma	0.000213	0.000246	CcSEcCtD
Isotretinoin—Nervousness—Timolol—glaucoma	0.000212	0.000245	CcSEcCtD
Isotretinoin—Skin disorder—Betaxolol—glaucoma	0.000212	0.000245	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CA1—glaucoma	0.000211	0.00154	CbGpPWpGaD
Isotretinoin—Vomiting—Dorzolamide—glaucoma	0.000211	0.000244	CcSEcCtD
Isotretinoin—Hyperhidrosis—Betaxolol—glaucoma	0.000211	0.000244	CcSEcCtD
Isotretinoin—Rash—Dorzolamide—glaucoma	0.000209	0.000242	CcSEcCtD
Isotretinoin—Dermatitis—Dorzolamide—glaucoma	0.000209	0.000242	CcSEcCtD
Isotretinoin—Rash—Travoprost—glaucoma	0.000208	0.000241	CcSEcCtD
Isotretinoin—Dermatitis—Travoprost—glaucoma	0.000208	0.000241	CcSEcCtD
Isotretinoin—Headache—Dorzolamide—glaucoma	0.000208	0.000241	CcSEcCtD
Isotretinoin—Anorexia—Betaxolol—glaucoma	0.000208	0.000241	CcSEcCtD
Isotretinoin—Vomiting—Brinzolamide—glaucoma	0.000207	0.00024	CcSEcCtD
Isotretinoin—Dizziness—Pilocarpine—glaucoma	0.000207	0.00024	CcSEcCtD
Isotretinoin—Headache—Travoprost—glaucoma	0.000207	0.00024	CcSEcCtD
Isotretinoin—Nausea—Brimonidine—glaucoma	0.000206	0.000239	CcSEcCtD
Isotretinoin—Feeling abnormal—Clonidine—glaucoma	0.000206	0.000239	CcSEcCtD
Isotretinoin—Rash—Brinzolamide—glaucoma	0.000206	0.000238	CcSEcCtD
Isotretinoin—Vision blurred—Timolol—glaucoma	0.000205	0.000238	CcSEcCtD
Isotretinoin—Dermatitis—Brinzolamide—glaucoma	0.000205	0.000238	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Clonidine—glaucoma	0.000205	0.000237	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CTSA—glaucoma	0.000204	0.00149	CbGpPWpGaD
Isotretinoin—Headache—Brinzolamide—glaucoma	0.000204	0.000237	CcSEcCtD
Isotretinoin—Hypotension—Betaxolol—glaucoma	0.000204	0.000236	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000203	0.00148	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—CDKN2B—glaucoma	0.000203	0.00148	CbGpPWpGaD
Isotretinoin—Vomiting—Pilocarpine—glaucoma	0.000199	0.000231	CcSEcCtD
Isotretinoin—Urticaria—Clonidine—glaucoma	0.000199	0.00023	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000198	0.00023	CcSEcCtD
Isotretinoin—Abdominal pain—Clonidine—glaucoma	0.000198	0.000229	CcSEcCtD
Isotretinoin—Body temperature increased—Clonidine—glaucoma	0.000198	0.000229	CcSEcCtD
Isotretinoin—Rash—Pilocarpine—glaucoma	0.000198	0.000229	CcSEcCtD
Isotretinoin—Dermatitis—Pilocarpine—glaucoma	0.000197	0.000229	CcSEcCtD
Isotretinoin—Insomnia—Betaxolol—glaucoma	0.000197	0.000228	CcSEcCtD
Isotretinoin—Nausea—Dorzolamide—glaucoma	0.000197	0.000228	CcSEcCtD
Isotretinoin—Headache—Pilocarpine—glaucoma	0.000196	0.000228	CcSEcCtD
Isotretinoin—Nausea—Travoprost—glaucoma	0.000196	0.000227	CcSEcCtD
Isotretinoin—Paraesthesia—Betaxolol—glaucoma	0.000196	0.000227	CcSEcCtD
Isotretinoin—Syncope—Timolol—glaucoma	0.000196	0.000227	CcSEcCtD
Isotretinoin—Dyspnoea—Betaxolol—glaucoma	0.000194	0.000225	CcSEcCtD
Isotretinoin—Nausea—Brinzolamide—glaucoma	0.000194	0.000224	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CA2—glaucoma	0.000193	0.0014	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000193	0.0014	CbGpPWpGaD
Isotretinoin—Palpitations—Timolol—glaucoma	0.000193	0.000223	CcSEcCtD
Isotretinoin—Dyspepsia—Betaxolol—glaucoma	0.000192	0.000222	CcSEcCtD
Isotretinoin—Loss of consciousness—Timolol—glaucoma	0.000192	0.000222	CcSEcCtD
Isotretinoin—Cough—Timolol—glaucoma	0.00019	0.000221	CcSEcCtD
Isotretinoin—Decreased appetite—Betaxolol—glaucoma	0.000189	0.000219	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—CDKN2B—glaucoma	0.000189	0.00138	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000189	0.00137	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000189	0.00137	CbGpPWpGaD
Isotretinoin—Hypertension—Timolol—glaucoma	0.000188	0.000218	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Betaxolol—glaucoma	0.000188	0.000218	CcSEcCtD
Isotretinoin—Fatigue—Betaxolol—glaucoma	0.000188	0.000218	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—TNF—glaucoma	0.000187	0.00136	CbGpPWpGaD
Isotretinoin—Pain—Betaxolol—glaucoma	0.000186	0.000216	CcSEcCtD
Isotretinoin—Constipation—Betaxolol—glaucoma	0.000186	0.000216	CcSEcCtD
Isotretinoin—Nausea—Pilocarpine—glaucoma	0.000186	0.000216	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—CDKN2B—glaucoma	0.000186	0.00135	CbGpPWpGaD
Isotretinoin—Chest pain—Timolol—glaucoma	0.000186	0.000215	CcSEcCtD
Isotretinoin—Myalgia—Timolol—glaucoma	0.000186	0.000215	CcSEcCtD
Isotretinoin—Arthralgia—Timolol—glaucoma	0.000186	0.000215	CcSEcCtD
Isotretinoin—Anxiety—Timolol—glaucoma	0.000185	0.000214	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000184	0.000214	CcSEcCtD
Isotretinoin—Hypersensitivity—Clonidine—glaucoma	0.000184	0.000214	CcSEcCtD
Isotretinoin—Discomfort—Timolol—glaucoma	0.000183	0.000213	CcSEcCtD
Isotretinoin—RARB—Gene Expression—CDKN2B—glaucoma	0.000182	0.00133	CbGpPWpGaD
Isotretinoin—Dry mouth—Timolol—glaucoma	0.000182	0.00021	CcSEcCtD
Isotretinoin—Asthenia—Clonidine—glaucoma	0.00018	0.000208	CcSEcCtD
Isotretinoin—Feeling abnormal—Betaxolol—glaucoma	0.000179	0.000208	CcSEcCtD
Isotretinoin—Confusional state—Timolol—glaucoma	0.000179	0.000208	CcSEcCtD
Isotretinoin—RARG—Gene Expression—NR3C1—glaucoma	0.000178	0.0013	CbGpPWpGaD
Isotretinoin—Oedema—Timolol—glaucoma	0.000178	0.000206	CcSEcCtD
Isotretinoin—Anaphylactic shock—Timolol—glaucoma	0.000178	0.000206	CcSEcCtD
Isotretinoin—Pruritus—Clonidine—glaucoma	0.000177	0.000205	CcSEcCtD
Isotretinoin—Infection—Timolol—glaucoma	0.000177	0.000205	CcSEcCtD
Isotretinoin—Shock—Timolol—glaucoma	0.000175	0.000203	CcSEcCtD
Isotretinoin—RARA—Gene Expression—CDKN2B—glaucoma	0.000175	0.00127	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—CDKN2B—glaucoma	0.000175	0.00127	CbGpPWpGaD
Isotretinoin—Nervous system disorder—Timolol—glaucoma	0.000175	0.000202	CcSEcCtD
Isotretinoin—Urticaria—Betaxolol—glaucoma	0.000173	0.000201	CcSEcCtD
Isotretinoin—Skin disorder—Timolol—glaucoma	0.000173	0.0002	CcSEcCtD
Isotretinoin—Body temperature increased—Betaxolol—glaucoma	0.000172	0.0002	CcSEcCtD
Isotretinoin—Hyperhidrosis—Timolol—glaucoma	0.000172	0.000199	CcSEcCtD
Isotretinoin—Diarrhoea—Clonidine—glaucoma	0.000171	0.000198	CcSEcCtD
Isotretinoin—Anorexia—Timolol—glaucoma	0.00017	0.000197	CcSEcCtD
Isotretinoin—Hypotension—Timolol—glaucoma	0.000166	0.000193	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—NR3C1—glaucoma	0.000166	0.00121	CbGpPWpGaD
Isotretinoin—Dizziness—Clonidine—glaucoma	0.000165	0.000192	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—NR3C1—glaucoma	0.000163	0.00119	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Timolol—glaucoma	0.000162	0.000188	CcSEcCtD
Isotretinoin—Insomnia—Timolol—glaucoma	0.000161	0.000187	CcSEcCtD
Isotretinoin—Hypersensitivity—Betaxolol—glaucoma	0.00016	0.000186	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.00016	0.00117	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NR3C1—glaucoma	0.00016	0.00116	CbGpPWpGaD
Isotretinoin—Paraesthesia—Timolol—glaucoma	0.00016	0.000185	CcSEcCtD
Isotretinoin—Vomiting—Clonidine—glaucoma	0.000159	0.000184	CcSEcCtD
Isotretinoin—Dyspnoea—Timolol—glaucoma	0.000159	0.000184	CcSEcCtD
Isotretinoin—Somnolence—Timolol—glaucoma	0.000158	0.000183	CcSEcCtD
Isotretinoin—Rash—Clonidine—glaucoma	0.000158	0.000183	CcSEcCtD
Isotretinoin—Dermatitis—Clonidine—glaucoma	0.000158	0.000183	CcSEcCtD
Isotretinoin—Headache—Clonidine—glaucoma	0.000157	0.000182	CcSEcCtD
Isotretinoin—Dyspepsia—Timolol—glaucoma	0.000157	0.000182	CcSEcCtD
Isotretinoin—Asthenia—Betaxolol—glaucoma	0.000156	0.000181	CcSEcCtD
Isotretinoin—Decreased appetite—Timolol—glaucoma	0.000155	0.000179	CcSEcCtD
Isotretinoin—Pruritus—Betaxolol—glaucoma	0.000154	0.000179	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Timolol—glaucoma	0.000154	0.000178	CcSEcCtD
Isotretinoin—Fatigue—Timolol—glaucoma	0.000153	0.000178	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—NR3C1—glaucoma	0.000153	0.00112	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NR3C1—glaucoma	0.000153	0.00112	CbGpPWpGaD
Isotretinoin—Pain—Timolol—glaucoma	0.000152	0.000176	CcSEcCtD
Isotretinoin—Diarrhoea—Betaxolol—glaucoma	0.000149	0.000173	CcSEcCtD
Isotretinoin—Nausea—Clonidine—glaucoma	0.000149	0.000172	CcSEcCtD
Isotretinoin—Feeling abnormal—Timolol—glaucoma	0.000147	0.00017	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Timolol—glaucoma	0.000146	0.000169	CcSEcCtD
Isotretinoin—Dizziness—Betaxolol—glaucoma	0.000144	0.000167	CcSEcCtD
Isotretinoin—Urticaria—Timolol—glaucoma	0.000141	0.000164	CcSEcCtD
Isotretinoin—Body temperature increased—Timolol—glaucoma	0.000141	0.000163	CcSEcCtD
Isotretinoin—Abdominal pain—Timolol—glaucoma	0.000141	0.000163	CcSEcCtD
Isotretinoin—Vomiting—Betaxolol—glaucoma	0.000138	0.000161	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000137	0.001	CbGpPWpGaD
Isotretinoin—Rash—Betaxolol—glaucoma	0.000137	0.000159	CcSEcCtD
Isotretinoin—Dermatitis—Betaxolol—glaucoma	0.000137	0.000159	CcSEcCtD
Isotretinoin—Headache—Betaxolol—glaucoma	0.000136	0.000158	CcSEcCtD
Isotretinoin—RXRA—Metabolism—TXN—glaucoma	0.000136	0.000989	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Timolol—glaucoma	0.000131	0.000152	CcSEcCtD
Isotretinoin—Nausea—Betaxolol—glaucoma	0.000129	0.00015	CcSEcCtD
Isotretinoin—Asthenia—Timolol—glaucoma	0.000128	0.000148	CcSEcCtD
Isotretinoin—Pruritus—Timolol—glaucoma	0.000126	0.000146	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000124	0.000903	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000123	0.000894	CbGpPWpGaD
Isotretinoin—Diarrhoea—Timolol—glaucoma	0.000122	0.000141	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000121	0.000882	CbGpPWpGaD
Isotretinoin—Dizziness—Timolol—glaucoma	0.000118	0.000136	CcSEcCtD
Isotretinoin—Vomiting—Timolol—glaucoma	0.000113	0.000131	CcSEcCtD
Isotretinoin—Rash—Timolol—glaucoma	0.000112	0.00013	CcSEcCtD
Isotretinoin—Dermatitis—Timolol—glaucoma	0.000112	0.00013	CcSEcCtD
Isotretinoin—Headache—Timolol—glaucoma	0.000111	0.000129	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—MMP2—glaucoma	0.000111	0.000808	CbGpPWpGaD
Isotretinoin—Nausea—Timolol—glaucoma	0.000106	0.000123	CcSEcCtD
Isotretinoin—RXRA—Metabolism—GSTT1—glaucoma	0.000105	0.000767	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—CDKN2B—glaucoma	9.1e-05	0.000663	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.5e-05	0.000619	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP1B1—glaucoma	8.4e-05	0.000611	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCA1—glaucoma	8.4e-05	0.000611	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MMP9—glaucoma	8.35e-05	0.000608	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NR3C1—glaucoma	7.99e-05	0.000581	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—VEGFA—glaucoma	7.49e-05	0.000546	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTM1—glaucoma	6.71e-05	0.000489	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TNF—glaucoma	6.42e-05	0.000468	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MTHFR—glaucoma	5.93e-05	0.000432	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—APOE—glaucoma	5.52e-05	0.000402	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CAV1—glaucoma	5.47e-05	0.000398	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NOS3—glaucoma	4.14e-05	0.000301	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS2—glaucoma	3.78e-05	0.000275	CbGpPWpGaD
